By National Nanotechnology Center (NANOTEC)
RMNS builds high-sensitivity biosensors and diagnostic devices for screening and monitoring of diseases, with expertise in biomarker identification and readout design. The work covers diabetes, kidney disease, cancer, and Alzheimer’s disease, among others using aptamer/peptide/protein targeting and nanoparticle-aided signal amplification to achieve performance in practical formats such as lateral-flow and electrochemical assays.
